Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 122 Breast Neoplasms 36 Prostatic Neoplasms 29 Insulin Resistance 27 Obesity 18 Pancreatic Neoplasms 14 Neoplasms 13 Endometrial Neoplasms 13 Infertility 12 Colorectal Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Anovulation 10 Lung Neoplasms 8 Neoplasm Metastasis 7 Metabolic Syndrome 7 Hyperandrogenism 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 5 Diabetes Mellitus 5 Adenocarcinoma 5 Weight Loss 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Diabetes Mellitus, Type 2 4 Brain Neoplasms 4

Interventions

Everolimus 8 Sunitinib 7 Temozolomide 5 Octreotide 4 Fluorouracil 4 lutetium Lu 177 dotatate 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Capecitabine 3 cabozantinib 2 Thalidomide 2 Streptozocin 2 Oxaliplatin 2 Irinotecan 2 Injections 2 Endoscopic Ultrasound-Guided Fine Needle Aspiration 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Bevacizumab 2 surufatinib 1 sargramostim 1 sapanisertib 1 recombinant interferon alpha 2b-like protein 1 pasireotide 1 napabucasin 1 motesanib diphosphate 1 montanide ISA 51 1 lanreotide 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02294006 2021-09-09

MetNET1

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡